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REDUCING THE BURDEN OF MEDICATION COSTS
TO IMPROVE MEDICATION ADHERENCE
SHAW, CHRISTINE R.
College of Nursing, Marquette University, Milwaukee, WI

ABSTRACT
The high cost of medications is one reason that patients do not adhere to
treatment plans. Providers can take actions to relieve the economic burden such
as prescribing generic medications and offering patients information on various
resources, including discount generic drug lists, discount cards, mail-order
pharmacies, and prescription assistance programs.
For many patients, controlling their health conditions depends not only on
lifestyle adaptations, but on adherence to a medication regimen. A review of the
research by Briesacher et al. illustrated that there is a significant problem with
medication regimen adherence due to cost-related factors.1 In the studies
reviewed, the inability to afford medications was the most consistent reason

among all age groups, especially older adults, for nonadherence to a medication
regimen. To help patients adhere to their regimens, prescribers must assess their
financial abilities to obtain medications. In addition, the prescriber must be aware
of a patient's insurance status and how it may affect medication costs.
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MEDICATION COVERAGE REALITIES
It is obvious that prescribing for the uninsured patient necessitates that the
prescriber consider strategies to make medications affordable. However, even
patients with prescription coverage may face high costs for medications. Some
insurance plans offer a tiered co-pay system; the co-pay rises depending on the
tier in which a drug is categorized. In other insurance plans, patients pay a
percentage (for example, 30%) of the cost of the medication. Either system may
result in prohibitively high costs depending on the choice of the medication
prescribed.
The prescriber also needs to be aware of the costs associated with Medicare Part
D.2 Patients pay a monthly insurance premium and often have a yearly deductible
before Part D begins to pay toward medications. In 2014, the deductible could be
up to $310 per year.2 After the deductible is met, Medicare Part D patients pay
either a tiered co-pay or a co-insurance percentage (such as 25%) of the cost of
each drug until they reach the “donut hole,” at which time their costs increase.
The “donut hole” is reached when a patient's medication costs, those paid by both
the patient and the insurer, exceed $2,790 a year. The Affordable Care Act (ACA)
will close the “donut hole” by 2020. (See Patient drug costs in the “donut hole.”)3

PRESCRIBER STRATEGIES TO REDUCE COSTS
As ordering generic medications can reduce costs, it is vital that the prescriber
has adequate knowledge of the appropriateness and availability of generic
medications for the individual's health conditions. Encouraging patients to provide
the prescriber with access to their insurer's formulary also allows the prescriber to
order the least expensive drugs.
Since not all medications have generic equivalents, it may be necessary to
prescribe alternative medications that, though still appropriate to the patient's
condition, may not be the drug chosen if cost were not an issue. For example, a

patient with a co-pay of 30% may find the monthly cost of a brand-name
combined corticosteroid and long-acting beta agonist (LABA) inhaler such as
fluticasone propionate and salmeterol (Advair HFA) to be too costly. However,
prescribing a generic inhaled corticosteroid without a LABA may be affordable to
the patient and still produce the desired anti-inflammatory effect and control
symptoms.
Another cost-reduction technique includes prescribing medication in a tablet form
at twice the required dose and instructing the patient to take half of a tablet. The
prescriber should give the patient written instructions with the name of the drug,
the exact dosage to be taken, and how often the drug should be taken. The
provider should also verify that the patient understands how to use a pill splitter
and document this information in the patient's medical record. This is an effective,
cost-reducing strategy if the cost of the higher-dosed tablet is not double the cost
of the lower dose. Pill splitters are inexpensive, and the added step of splitting the
pill is a simple trade-off for a less expensive drug.

LOW-COST DRUG RESOURCES
There are several other approaches to reducing patient medication costs. (See
Medication cost reduction resources.)
NeedyMeds is a reliable, non-profit, patient-friendly website that requires no
registration and contains a wealth of information on access to low-cost, generic or
free, brand-name drugs.4 It provides information on pharmacy assistance
programs (PAPs), mail-order discount drug pharmacies, coupons, rebates,
reduced-cost diagnostic tests, and patient education. The site also provides a free
drug discount card that can reduce the cost of drugs at retail pharmacies and
information on state and national programs that reduce the cost of healthcare and
medications for patients. The major pharmaceutical companies also sponsor a
resource website, Partnership for Prescription Assistance, which provides similar
patient information.5

PHARMACY ASSISTANCE PROGRAMS
PAPs are sponsored by pharmaceutical companies to provide free brand-name
medications to those who are eligible. An application form is required for each
pharmaceutical company from which a drug is sought.
PAPs are usually used by patients with low-to-moderate incomes and those who
do not have medication insurance coverage. Some programs allow access via
Medicare patients during the “donut hole,” whereas others do not. Income

standards are based on federal poverty guidelines
(aspe.hhs.gov/poverty/13poverty.cfm). In addition, patient eligibility
requirements differ depending on the pharmaceutical company and are described
on the application materials. Applications require demographic and contact
information for the patient as well as financial information, including proof of
income.
Certain programs accept a W2 form or several months of pay stubs, whereas
others require a copy of the previous year's Federal Internal Revenue Service
(IRS) forms. If income tax forms were not filed, proof of nonfiling may be
required from the IRS. This is done by the patient submitting a Request for
Transcript of Tax Return 4506-T, which takes 4 to 6 weeks to process.
PAPs provide a wide range of brand name medications that do not have generic
formulations. Three- to four-month supplies of brand-name medications are
provided free of charge for 1 year with the option for renewal. Medications are
delivered to the prescriber's office or the patient's home, depending on company
policy. There is no charge by the pharmaceutical companies for the application or
the medications covered by the PAP. A patient or the prescriber can initiate the
application process. The process usually requires Internet access and basic
computer skills.
There are some limitations on available medications. Drugs previously included in
the program may be discontinued as they become available in generic form. The
initial application process takes 3 to 4 weeks before the patient will receive the
first shipment of medications. Subsequent refills are sent within 7 to 10 days of
the request. The process of obtaining and completing the application forms may
be time consuming if the prescriber takes this responsibility. Patients with
Internet access and minimal computer skills who are supplied with the
NeedyMeds web address and a list of their medications can access and complete
the forms requiring only the prescriber signature and prescription.
NeedyMeds (http://www.needymeds.org/index.htm) and Partnership for
Prescription Assistance (https://www.pparx.org/en) provide links to PAP
application forms for specific drugs, pharmaceutical companies, and medical
conditions. PAPs can also be found directly at individual pharmaceutical
companies' websites. Proprietary companies also exist, which, for a monthly or
per-drug fee, assist the patient with locating and completing the PAP application.
These services still require a list of the patient medications, the signature of the
prescriber, and a prescription for each medication. Examples include: Rx Assist
(http://www.rxassist.org), Prescription Assistance Advocacy 360
(http://www.prescriptionassistance360.org/), and Select Care Benefits Network
(SCBN) Prescription Advocacy (http://www.scbn.org/).

EMPOWERING PATIENTS
To enhance medication adherence, prescribers must assess a patient's financial
ability to obtain medication. Prescriber awareness of generic drug alternatives,
cost-savings options, and discounts offered by various states and pharmacies is
vital to assuring that a patient will have access to the prescribed medications.
Advising patients on the available resources and encouraging their use may assist
patients in obtaining medications they can afford. Empowering patients to take
responsibility in finding affordable medications reduces the time commitment of
the prescriber and, more importantly, helps patients better control their
healthcare condition.
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